Tabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade

Reference:
Product nameTabalumab Biosimilar - Anti-TNFSF13B, CD257 mAb - Research Grade
SourceCAS 1143503-67-6
SpeciesHomo sapiens
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsTabalumab,LY2127399,TNFSF13B, CD257,anti-TNFSF13B, CD257
ReferencePX-TA1275
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Tabalumab Biosimilar - Anti-TNFSF13B/CD257 mAb - Research Grade

General information on Anti-TNFSF13B/CD257[Homo sapiens] (Tabalumab) Monoclonal Antibody

Tabalumab has been investigated for the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Tabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD257 / BAFF / TNFSF13B, C-His, recombinant protein
Antigen

CD257 / BAFF / TNFSF13B, C-His, recombinant protein

PX-P5600 404$
CD257 Recombinant Protein
Antigen

CD257 Recombinant Protein

PX-P4112 426$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 189$
Stable Isotope Labelled Tabalumab Biosimilar – Anti-TNFSF13B/CD257 mAb – Research Grade
SIL

Stable Isotope Labelled Tabalumab Biosimilar – Anti-TNFSF13B/CD257 mAb – Research Grade

PX-TA1275-SIL 15750$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products